Associate Director of National Intelligence and Chief Information Officer

Global Product Management: Navigating Regulatory Pressures with Automation & Interconnected Data, Upcoming Webinar Hosted by Xtalks

Retrieved on:

Tuesday, April 25, 2023

Pharmacovigilance, Life, Artificial intelligence, Agency for Medicinal Products and Medical Devices of the Republic of Slovenia, Associate Director of National Intelligence and Chief Information Officer, HL7, FHIR, Fast Healthcare Interoperability Resources, Automation, Medical device

TORONTO, April 25, 2023 /PRNewswire-PRWeb/ -- Life sciences companies face mounting internal pressures such as inflation, sourcing and manufacturing uncertainty and ever evolving global regulations. Additionally, internal pressures are calling for teams to operate lean and leverage data to solve problems. Together, these external and internal forces present a new wave of challenges for regulatory affairs and operations professionals, especially when managing a sprawling, global product portfolio.

Key Points:

In this free webinar, learn how interconnected regulatory data can enable every aspect of life sciences and inform strategic decisions.
Attendees will gain insights into the role of automation in creating efficiencies and reducing costs for regulatory affairs and operations.
The featured speakers will discuss regulatory's connection to pharmacovigilance and its role in improving patient safety through global product data standards.
Join this webinar as ArisGlobal regulatory leaders highlight the potential of intelligent automation and interconnected regulatory data to inform strategic decisions and other key strategies for proactive management of a global product portfolio.

Wendy Reinhardt Kapsak Appointed Chief Executive Officer, International Food Information Council

Retrieved on:

Monday, April 24, 2023

Washington, DC, April 24, 2023 (GLOBE NEWSWIRE) -- The International Food Information Council (IFIC) announced the appointment of Wendy Reinhardt Kapsak, MS, RDN as its new Chief Executive Officer effective May 1.

Key Points:

Washington, DC, April 24, 2023 (GLOBE NEWSWIRE) -- The International Food Information Council (IFIC) announced the appointment of Wendy Reinhardt Kapsak, MS, RDN as its new Chief Executive Officer effective May 1.
A visionary leader with extensive experience in food, nutrition, and agriculture business strategies, Reinhardt Kapsak is uniquely poised to help IFIC deliver on its mission to effectively communicate science-based information about sustainable food systems, with a focus on food safety and nutrition.
“Wendy’s transformative and results-oriented leadership, coupled with her significant food and nutrition experience in various sectors, make her the ideal candidate to lead IFIC into the future,” said Russell Dyer, IFIC Co-Chair and Chief Communications Officer, Mondelēz International.
Reinhardt Kapsak also has extensive industry experience, including leadership positions in the Food, Nutrition & Health Partnerships and Corporate Engagement verticals in what is now collectively known as Bayer Crop Science.

Parexel Appoints Scott Smith, M.D., Ph.D. as New Head of Hematology

Retrieved on:

Wednesday, April 19, 2023

In this role, Dr. Smith will lead Parexel’s Hematology therapeutic area and global team within our Oncology Center of Excellence in the development of new treatments for malignant hematology diseases as well as in the development of new therapies to treat non-malignant hematology diseases.

Key Points:

In this role, Dr. Smith will lead Parexel’s Hematology therapeutic area and global team within our Oncology Center of Excellence in the development of new treatments for malignant hematology diseases as well as in the development of new therapies to treat non-malignant hematology diseases.
Prior to joining Parexel, Scott held several positions of increasing responsibility at Loyola Medicine's Cardinal Bernardin Cancer Center, including Director, Cancer Clinical Trials Office; Director, Bone Marrow Transplant Program; Section Chief of Hematology; and Associate Director, Clinical Research.
Dr. Smith’s experience also includes serving as Executive Officer for the Alliance of Clinical Trials in Oncology in Chicago, leading the group’s hematology research portfolio.
“At Parexel, we are passionate about achieving better outcomes for patients,” added Peyton Howell, Chief Operating and Growth Officer.

ZyVersa Therapeutics Announces Article Published in Brain Pathology Addressing Inflammasome Signaling Proteins in Alzheimer’s Disease

Retrieved on:

Monday, April 10, 2023

In the paper titled, “Identification of inflammasome signaling proteins in neurons and microglia in early and intermediate stages of Alzheimer’s disease,” the researchers observed expression of the inflammasome NLRP1 sensor mainly in neurons, while inflammasome sensor NLRP3 was detected mainly in microglia of donors with low and intermediate AD pathology.

Key Points:

In the paper titled, “Identification of inflammasome signaling proteins in neurons and microglia in early and intermediate stages of Alzheimer’s disease,” the researchers observed expression of the inflammasome NLRP1 sensor mainly in neurons, while inflammasome sensor NLRP3 was detected mainly in microglia of donors with low and intermediate AD pathology.
“Inflammasome activation is implicated in the early stages of AD, but the cell types that express inflammasomes have remained undefined.
This study demonstrates that IC 100 identifies neurons in areas of the brain that are particularly susceptible to death in the early and intermediate stages of the disease process.
Preclinical studies have demonstrated reduced inflammatory activity and/or improved outcomes in multiple sclerosis, age-related inflammation, spinal cord injury, and two different models of brain injury.”

Axiom Exhibiting at Clinical Trial Supply New England 2023

Retrieved on:

Tuesday, April 4, 2023

Axiom, Associate Director of National Intelligence and Chief Information Officer, Clinical trial, Clinical data management, Global studies, Metric, IRT, Pharmaceutical industry, Computer data storage

TORONTO, April 04, 2023 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), a premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will be exhibiting at Clinical Trial Supply New England 2023, April 5-6 in Boston, Massachusetts.

Key Points:

TORONTO, April 04, 2023 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), a premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will be exhibiting at Clinical Trial Supply New England 2023, April 5-6 in Boston, Massachusetts.
The Clinical Trial Supply series is a unique platform for clinical trial sponsors and solution providers to connect and explore ways to overcome challenges associated with clinical trial supply chain, inclusive of RTSM, IRT, Inventory Management and simplifying these key processes.
This allows RTSM managers to easily define and manage complex randomization schemes while efficiently monitoring drug supply levels in real-time.
The result is an optimized distribution of clinical trial materials to trial sites.

Arthur D. Little Appoints Eleven New Partners Across Global Offices

Retrieved on:

Tuesday, April 11, 2023

Arthur D. Little (ADL) today announced the election of eleven of its consultants to the rank of Partner across a number of its global offices.

Key Points:

Arthur D. Little (ADL) today announced the election of eleven of its consultants to the rank of Partner across a number of its global offices.
View the full release here: https://www.businesswire.com/news/home/20230411005624/en/
Arthur D. Little promotes eleven new partners (Graphic: Business Wire)
Every one of these new Partners combines best-in-class experience and expertise with deep understanding and dedication to the industries and clients that they work with.
He's further advancing our services for ports & maritime clients, while simultaneously expanding our automotive business presence in the Middle East.
Hirotaka has been integral to the expansion of Arthur D. Little in Thailand and leads the AMG practice in SEA.

The Sino-American Pharmaceutical Professionals Association-Greater Philadelphia (SAPA-GP) Hosted the 2023 Annual Conference

Retrieved on:

Monday, April 3, 2023

https://sapagp.org/ ) hosted its 21st Annual Conference at the Sheraton Valley Forge Hotel northwest of Philadelphia.

Key Points:

https://sapagp.org/ ) hosted its 21st Annual Conference at the Sheraton Valley Forge Hotel northwest of Philadelphia.
The conference was a major event in the greater Philadelphia area, sponsored by twenty-six companies and attended by over five-hundred life scientists, pharmaceutical professionals, and business executives.
To capture the new reality of the biopharma industry, the 2023 annual conference featured a balanced programming on science, technology, business, and career development.
The 2023 SAPA-GP Annual Conference was an invigorating community gathering of life scientists, pharmaceutical professionals, and business executives representing all backgrounds, experiences, and achievements.

Abounding Prosperity Board of Directors Unanimously Appoints Tamara Stephney as Acting CEO

Retrieved on:

Friday, April 7, 2023

Associate Director of National Intelligence and Chief Information Officer, State, Life, HIV, Public, Prosperity, Black, Organization, Hepatitis, Acting, Health, Memory, Management, Nursing

DALLAS, April 7, 2023 /PRNewswire/ -- Amid the passing of Mr. Kirk D. Myers-Hill, the Founder and Chief Executive Officer of Abounding Prosperity, Inc. , the Board of Directors announces the appointment of Ms. Tamara Stephney as Acting Chief Executive Officer of Abounding Prosperity, Inc.

Key Points:

DALLAS, April 7, 2023 /PRNewswire/ -- Amid the passing of Mr. Kirk D. Myers-Hill, the Founder and Chief Executive Officer of Abounding Prosperity, Inc. , the Board of Directors announces the appointment of Ms. Tamara Stephney as Acting Chief Executive Officer of Abounding Prosperity, Inc.
The Board of Directors of Abounding Prosperity, Inc., met for an emergency meeting on the evening of April 4th and unanimously voted to appoint Ms. Stephney to the role.
We, the Board of Directors, have no doubt that she is well suited to further advance the mission of Abounding Prosperity, Inc., and the legacy of Mr. Myers-Hill," said Michelle Myers, board chair.
Tamara Stephney is a long-standing, committed and visible part of Abounding Prosperity.

ESG: Creating Greener Clinical Trials, Upcoming Webinar Hosted by Xtalks

Retrieved on:

Wednesday, April 5, 2023

Organization, Biophysical environment, Clinical trial, ESG, Associate Director of National Intelligence and Chief Information Officer, Social, Syneos Health, Environment, Risk, Management, Nursing

TORONTO, April 5, 2023 /PRNewswire-PRWeb/ -- Every company uses energy and resources; every company affects, and is affected by, the environment. Every company operates within a broader, diverse society. Every company requires governance to function, operate and exist. Environmental, social and governance (ESG) imperatives impact every aspect of clinical trial operations. ESG is a collective term that measures a business's impact on the environment, society at large and how robust and transparent its governance is in terms of company leadership, executive pay, audits, internal controls and shareholder rights.

Key Points:

The featured speakers will discuss how clinical operations leaders should plan for their organization's ESG priorities.
TORONTO, April 5, 2023 /PRNewswire-PRWeb/ -- Every company uses energy and resources; every company affects, and is affected by, the environment.
Join this webinar to learn how ESG will have a profound impact on how clinical operations work is performed.
By understanding an organization's position and needs, Clinical Operations Leaders have an opportunity to take an industry leading position in ESG.

Universal Display Corporation Sponsors and Presents at ICDT 2023

Retrieved on:

Tuesday, March 28, 2023

Universal Display Corporation (Nasdaq: OLED), enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, today announced its sponsorship and presentation at the International Conference on Display Technology (ICDT) 2023 (2023国际显示技术大会) .

Key Points:

Universal Display Corporation (Nasdaq: OLED), enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, today announced its sponsorship and presentation at the International Conference on Display Technology (ICDT) 2023 (2023国际显示技术大会) .
Hosted by the Society for Information Display (SID), ICDT 2023 will be held March 31-April 3 at Nanjing International Exhibition Center, China.
“We are pleased to share our cutting-edge research work at the upcoming ICDT 2023 and to continue our sponsorship of this global display symposium and exhibition in China,” said Steven V. Abramson, President and Chief Executive Officer of Universal Display Corporation.
Session 32: OLED Displays (OLEDs), where Dr. Mike Weaver, Vice President, PHOLED R&D, of Universal Display will virtually present his Invited Paper on “Future OLED Displays,” on Monday, April 3rd at 8:30 AM CST.